- Report
- July 2024
- 280 Pages
Global
From €2516EUR$2,655USD£2,102GBP
- Book
- June 2024
- 496 Pages
- Book
- December 2019
- 432 Pages
- Book
- December 2019
- 432 Pages
- Book
- January 2019
- 600 Pages
- Book
- January 2016
- 952 Pages
- Book
- March 2023
North America
- Book
- May 2019
North America
Iron overload is a condition in which the body accumulates too much iron, which can lead to organ damage. It is a common complication of certain blood disorders, such as thalassemia and sickle cell anemia, and can also be caused by certain medications, such as those used to treat Central Nervous System (CNS) diseases. Iron overload can cause a variety of symptoms, including fatigue, joint pain, and abdominal pain. Treatment typically involves chelation therapy, which involves the use of drugs to remove excess iron from the body.
The Iron Overload market is a subset of the CNS drugs market, and is focused on the development of drugs to treat iron overload. These drugs are typically chelators, which bind to iron and remove it from the body. The market is highly competitive, with a number of companies developing new drugs to treat iron overload.
Some companies in the Iron Overload market include Sanofi, Pfizer, Novartis, and GlaxoSmithKline. Show Less Read more